Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001839882-25-009559·Sionna Therapeutics, Inc.
Schedule 13D ownership disclosure
Sionna Therapeutics Inc
Common Stock, par value $0.001 per share · CUSIP: 829401108
Event date: 2025-02-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TPG GP A, LLCReported CIK 0001903793
Shares: 6,684,962.00 · Class: 15.2%
- James G. CoulterReported CIK 0001099776
Shares: 6,684,962.00 · Class: 15.2%
- Jon WinkelriedReported CIK 0001366946
Shares: 6,684,962.00 · Class: 15.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001839882-25-009559
- Form type
- SCHEDULE 13D
- Filer
- Sionna Therapeutics, Inc.
- CIK
- CIK 2036042
- Filed
- Feb 18, 2025
- Reporting period
- Feb 10, 2025
- Description
- Schedule 13D beneficial ownership